MICOT PHARMA-B (02335) proposes to adopt an H share incentive scheme and seeks shareholders' authorization for H share repurchase
MICOT PHARMA-B (02335) announced that on October 15, 2026 (after trading hours), the Board resolved to propose the adoption of an H share incentive scheme for shareholder approval, and will seek shareholder authorization for an H share repurchase mandate at the extraordinary general meeting convened by the Company.
MICOT PHARMA-B (02335) announced that on October 15, 2026 (after trading hours), the Board resolved to propose the adoption of an H share incentive scheme for shareholder approval, and will seek shareholder authorization for an H share repurchase mandate at an extraordinary general meeting convened by the company.
Related Articles
Jiangxi Sanxin Medtec (300453.SZ) plans to repurchase shares for an amount between RMB 30 million and RMB 60 million.
Ganzhou Yihao New Materials (301176.SZ) plans to launch a 2026 restricted stock incentive plan.
Technological leadership yet undervalued! Quantinuum (QNT.US) upgraded by Morgan Stanley to "Overweight" and named a top pick in the quantum computing sector.
Jiangxi Sanxin Medtec (300453.SZ) plans to repurchase shares for an amount between RMB 30 million and RMB 60 million.
Ganzhou Yihao New Materials (301176.SZ) plans to launch a 2026 restricted stock incentive plan.
Technological leadership yet undervalued! Quantinuum (QNT.US) upgraded by Morgan Stanley to "Overweight" and named a top pick in the quantum computing sector.
